Form 8-K - Current report:
SEC Accession No. 0001104659-25-042570
Filing Date
2025-04-30
Accepted
2025-04-30 16:30:25
Documents
16
Period of Report
2025-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513615d1_8k.htm   iXBRL 8-K 34088
2 EXHIBIT 10.1 tm2513615d1_ex10-1.htm EX-10.1 317329
6 GRAPHIC tm2513615d1_ex10-1img01.jpg GRAPHIC 1173
7 GRAPHIC tm2513615d1_ex10-1img02.jpg GRAPHIC 965
  Complete submission text file 0001104659-25-042570.txt   592648

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20250424.xsd EX-101.SCH 3014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20250424_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20250424_pre.xml EX-101.PRE 22358
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2513615d1_8k_htm.xml XML 3668
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 25895932
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)